Skip to main content

Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors

  • Chapter
Brain Tumor Invasiveness

Abstract

Mouse and human melanoma cells metastatic to the brain express degradative enzyme activities that are used for invasion of brain basement membrane and parenchyma. Compared to poorly metastatic or lung- or ovary-metastatic murine melanoma lines, the brain-metastatic sublines secreted higher levels of a variety of degradative enzymes. Brain-metastatic murine and human melanoma cells also degraded subendothelial basement membrane and reconstituted basement membrane at rates higher than other metastatic melanoma cells. In some cases these degradative activities in mouse and human melanoma cells can be induced by paracrine factors known to be present in the brain parenchyma, such as nerve growth factor (NGF). NGF stimulates the expression of degradative enzymes, such as the endo-ß-glucuronidase heparanase, that are important in basement membrane penetration but this factor does not stimulate melanoma cell growth. The growth of brain-metastasizing melanoma cells appears to be stimulated by other paracrine growth factors, such as paracrine transferrin. Melanoma cells metastatic to brain express higher numbers of transferrin receptors and respond and proliferate at lower concentrations of transferrin than do melanoma cells metastatic to other sites or poorly metastatic melanoma cells. The results suggest that degradation and invasion of brain basement membrane and responses to paracrine neurotrophins and paracrine transferrins are important properties in brain metastasis of murine and human malignant melanoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Liotta LA, Rao CN, Wewer UM: Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55:1037–1057, 1986

    Article  PubMed  CAS  Google Scholar 

  2. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in colonization of specific secondary sites. Biochim Biophys Acta 948:175–224,1988

    PubMed  CAS  Google Scholar 

  3. Nicolson GL: Tumor and host molecules important in organ preference of metastasis. Semin Cancer Biol 2:143–154, 1991

    PubMed  CAS  Google Scholar 

  4. Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev. 12: 325–343, 1993

    Article  PubMed  CAS  Google Scholar 

  5. Sugarbaker EV: Patterns of metastasis in human malignancies. Cancer Biol Rev 2: 235–278, 1983

    Google Scholar 

  6. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571–573, 1889

    Article  Google Scholar 

  7. Steck PA, Nicolson GL: Metastases to the central nervous system. In: Levine A, Schmidek H (eds) Molecular Genetics of Nervous System Tumors, pp 371–379, Wiley-Liss, New York, 1993

    Google Scholar 

  8. Einhorn LH, Burgess MA, Vallejos C, Bodey GP, Gutter-man J, Mavligit G, Hersh EM, Luce JK, Frei E, Freireich EJ, Gottlieb JA: Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res 34:1995–2004, 1974

    PubMed  CAS  Google Scholar 

  9. Patel JK, Didolkar MS, Pickren JW, Moore RH: Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135: 807–810, 1987

    Article  Google Scholar 

  10. de la Monte SM, Moore GW, Hutchin M: Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 43: 3427–3432, 1983

    PubMed  Google Scholar 

  11. Chason JL, Walker FB, Landers JW: Metastatic carcinoma of the central nervous system and dorsal root ganglia: a prospective autopsy study. Cancer 16: 781–787, 1963

    Article  PubMed  CAS  Google Scholar 

  12. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK: Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42: 660–668, 1978

    Article  PubMed  CAS  Google Scholar 

  13. Byrne TN, Cascino TL, Posner JB: Brain metastasis from melanoma. J Neuro-Oncol 1: 313–317, 1981

    Article  Google Scholar 

  14. Brunson KE, Beattie G, Nicolson GL: Selection and altered properties of brain-colonizing melanoma. Nature 272: 543–545, 1978

    Article  PubMed  CAS  Google Scholar 

  15. Miner KM, Kawaguchi T, Uba GW, Nicolson GL: Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain-meninges-colonizing murine B16 melanoma. Cancer Res 42: 4631–4638, 1982

    PubMed  CAS  Google Scholar 

  16. Kawaguchi T, Kawaguchi M, Dulski K, Nicolson GL: Cellular behavior of metastatic B16 melanoma in experimental blood-borne implantation and cerebral invasion. Invasion Metastasis 5:16–30, 1985

    PubMed  CAS  Google Scholar 

  17. Kawaguchi T, Kawaguchi M, Lembo T, Nicolson GL: Differential tumor growth of blood-borne B16 melanoma variants in cerebral dura mater is related to tumor-host reactions. Clin Exp Metastasis 7:1–14, 1989

    Article  PubMed  CAS  Google Scholar 

  18. Schackert G, Fidler IJ: Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48: 3478–3484, 1988

    PubMed  CAS  Google Scholar 

  19. Schackert G, Price JE, Zhaang R, Bucana CD, Itoh K, Fidler IJ: Regional growth of different human melanomas as metastases in the brain of nude mice. Am J Pathol 136: 95–102, 1990

    PubMed  CAS  Google Scholar 

  20. Ishikawa M, Fernandez B, Kerbel RS: Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain. Cancer Res 48:4897–4903, 1988

    PubMed  CAS  Google Scholar 

  21. Nicolson GL, Kawaguchi T, Kawaguchi M, Van Pelt C: Brain surface invasion and metastasis of murine malignant melanoma variants. J Neuro-Oncology 4: 209–218, 1987

    Article  CAS  Google Scholar 

  22. Marchetti D, Menter D, Jin L, Nakajima M, Nicolson GL: Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 55: 693–699, 1993

    Article  Google Scholar 

  23. Belloni PN, Carney DH, Nicolson GL: Organ-derived endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res 43: 20–45, 1992

    Article  PubMed  CAS  Google Scholar 

  24. Nakajima M, Irimura T, DiFerrante DT, DiFerrante N, Nicolson GL: Heparan sulfate degradation correlates with tumor invasive and metastatic properties of B16 melanoma sublines. Science 220: 611–613, 1983

    Article  PubMed  CAS  Google Scholar 

  25. Nakajima M, Irimura T, Di Ferrante N, Nicolson GL: Metastatic melanoma cell heparanase: characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259: 2283–2290, 1984

    PubMed  CAS  Google Scholar 

  26. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, cathep-sin L. Meth Enzyol 80: 535–561, 1981

    Article  CAS  Google Scholar 

  27. Barrett AJ: Cathepsin D: purification of isoenzymes from human and chicken liver. Biochem J 117: 601–607, 1970

    PubMed  CAS  Google Scholar 

  28. Nakajima M, Welch DR, Belloni PN, Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869–4876, 1987

    PubMed  CAS  Google Scholar 

  29. Albini A, Iwamoto Y, Kleinmann HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245, 1987

    PubMed  CAS  Google Scholar 

  30. Herrmann JL, Menter DG, Hamada J-I, Marchetti D, Nakajima M, Nicolson GL: Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: Melanoma p75 functions independent of trkA. Mol Biol Cell 4:1205–216, 1993

    PubMed  CAS  Google Scholar 

  31. Inoue T, Cavanaugh PG, Nicolson GL: Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol 156: 212–217, 1993

    Article  PubMed  CAS  Google Scholar 

  32. Nicolson GL, Inoue T, Van Pelt CS, Cavanaugh PG: Differential expression of a Mr ~ 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization. Cancer Res 50: 515–520, 1990

    PubMed  CAS  Google Scholar 

  33. Cavanaugh PG, Nicolson GL: Purification and characterization of a Mr 66,000 lung-derived paracrine growth factor that preferentially stimulates the in vitro proliferation of lung metastasizing tumor cells. J Cell Biochem 43:127–138, 1990

    Article  PubMed  CAS  Google Scholar 

  34. Nicolson GL: Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers. J Histochem Cytochem 30: 214–220, 1982

    Article  PubMed  CAS  Google Scholar 

  35. Auerbach RL, Alby L, Morrissey W, Joseph J: Expression of organ specific antigens on capillary endothelial cells. Micro-vase Res 29: 401–411, 1985

    Article  CAS  Google Scholar 

  36. Belloni PN, Nicolson GL: Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cell cultures. J Cell Physiol 136: 398–410, 1988

    Article  PubMed  CAS  Google Scholar 

  37. Hempstead BL, Martin ZD, Kaplan DR, Parada LF, Chao MV: High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350: 678–683, 1991

    Article  PubMed  CAS  Google Scholar 

  38. Herlyn M, Kath R, Williams N, Valyi-Nagy I, Rodeck V: Growth regulatory factors for normal, premalignant and malignant human cells. Adv Cancer Res 54: 213–234, 1990

    Article  PubMed  CAS  Google Scholar 

  39. Nicolson GL: Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204:171–180, 1993

    Article  PubMed  CAS  Google Scholar 

  40. Nicolson GL, Dulski KM: Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 38: 289–294, 1986

    Article  PubMed  CAS  Google Scholar 

  41. Cavanaugh PG, Nicolson GL: Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cell metastatic to the lung. Cancer Res 49: 3928–3933, 1989

    PubMed  CAS  Google Scholar 

  42. Cavanaugh PG, Nicolson GL: Lung-derived growth factor that stimulates the growth of lung-metastasizing tumor cells: Identification as transferrin. J Cell Biochem 47: 261–271, 1991

    Article  PubMed  CAS  Google Scholar 

  43. Nicolson GL, Cavanaugh PG, Inoue T: Differential stimulation of the growth of lung-metastasizing tumor cells by lung (paracrine) growth factors: Identification of transferrin-like mitogens in lung tissue-conditioned medium. J Nat Cancer Inst Mgr 13:153–161, 1992

    Google Scholar 

  44. Rodeck U, Becker D, Herlyn M: Basic fibroblast growth factor in human melanoma. Cancer Cells 3: 308–312, 1991

    PubMed  CAS  Google Scholar 

  45. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47:1473–1487, 1987

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Nicolson, G.L. et al. (1994). Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. In: Goldfarb, R.H. (eds) Brain Tumor Invasiveness. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2622-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2622-3_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6124-4

  • Online ISBN: 978-1-4615-2622-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics